C. Chira

479 citations

34 papers · 333 indexed · h-index 9

Impact in

Radiation top 5%
- Advanced Radiotherapy Techniques
Pulmonary and Respiratory Medicine
- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Treatment and Research
- Brain Metastases and Treatment

Papers in ⓘ

Pulmonary and Respiratory Medicine 25
- Brain Metastases and Treatment 10
- Prostate Cancer Diagnosis and Treatment 9
- Prostate Cancer Treatment and Research 6
Oncology 15
- Cancer Immunotherapy and Biomarkers 4

Co-authors: V. Beckendorf (5 shared papers)R. de Crevoisier (9 shared papers)S. Boulinguez (7 shared papers)V. Sibaud (9 shared papers)Nicolás Meyer (8 shared papers)A. Modesto (7 shared papers)Léonor Chaltiel (6 shared papers)Oscar Acosta (3 shared papers)
Journals: Melanoma Research (3 papers)International Journal of Radiation Oncology*Biology*Physics (2 papers)The Breast (2 papers)Cancers (2 papers)Radiation Oncology (2 papers)
Partner nations: France Colombia United States

In The Last Decade

C. Chira

29 papers receiving 329 citations

Peers

Countries citing papers authored by C. Chira

Since Specialization

Citations

This map shows the geographic impact of C. Chira's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Chira with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Chira more than expected).

Fields of papers citing papers by C. Chira

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Chira. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Chira. The network helps show where C. Chira may publish in the future.

Co-authors

The 25 scholars most cited alongside C. Chira, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with C. Chira Line = papers co-authored together C. Chira links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Concurrent radiotherapy for patients with metastatic melanoma and receiving anti-programmed-death 1 therapy: a safe and effective combination Melanoma Research ·A. Aboudaram, A. Modesto, Léonor Chaltiel, Carlos Gomez‐Roca, S. Boulinguez, V. Sibaud, Jean‐Pierre Delord, C. Chira, M. Delannes, Elizabeth Cohen‐Jonathan Moyal, Nicolás Meyer	2017	80
2	Random Forests to Predict Rectal Toxicity Following Prostate Cancer Radiation Therapy International Journal of Radiation OncologyBiologyPhysics ·Juan David Ospina, Jian Zhu, C. Chira, Alberto Bossi, Jean Bernard Delobel, V. Beckendorf, Bernard Dubray, Jean‐Léon Lagrange, Juan Carlos Correa, Antoine Simon, Oscar Acosta, R. de Crevoisier	2014	44
3	Nomogram to predict rectal toxicity following prostate cancer radiotherapy PLoS ONE ·Jean-Bernard Delobel, K. Gnep, Juan David Ospina, V. Beckendorf, C. Chira, Jian Zhu, Alberto Bossi, T. Messaï, Oscar Acosta, J. Castelli, R. de Crevoisier	2017	31
4	Nomograms to predict late urinary toxicity after prostate cancer radiotherapy World Journal of Urology ·Romain Mathiéu, Juan David Ospina, V. Beckendorf, Jean-Bernard Delobel, T. Messaï, C. Chira, Alberto Bossi, É. Le Prisé, S. Guérif, Antoine Simon, Bernard Dubray, Jian Zhu, Jean‐Léon Lagrange, P. Pommier, K. Gnep, Oscar Acosta, R. de Crevoisier	2013	28
5	Intensity-modulated radiation therapy from 70Gy to 80Gy in prostate cancer: six- year outcomes and predictors of late toxicity Radiation Oncology ·Maria Jolnerovski, Julia Salleron, V. Beckendorf, D. Peiffert, A.-S. Baumann, V. Bernier, S. Huger, V. Marchesi, C. Chira	2017	26
6	Helical Tomotherapy for Inoperable Breast Cancer: A New Promising Tool BioMed Research International ·C. Chira, Youlia Kirova, X. Liem, François Campana, D. Peurien, M. Amessis, N. Fournier‐Bidoz, Jean‐Yves Pierga, R. Dendale, Pierre Bey, Alain Fourquet	2013	21
7	Prostate volume changes during permanent seed brachytherapy: an analysis of intra-operative variations, predictive factors and clinical implication Radiation Oncology ·C. Chira, Guila Delouya, Sandra Larrivée, Jean‐François Carrier, Daniel Taussky	2013	16
8	Résultats préliminaires d’une tomothérapie hélicoïdale adjuvante avec boost intégré dans le cadre d’un traitement conservateur d’un cancer du sein Cancer/Radiothérapie ·X. Liem, C. Chira, Alain Fourquet, F. Campana, D. Peurien, N. Fournier‐Bidoz, Youlia Kirova	2013	15
9	Toxicités dermatologiques des inhibiteurs de checkpoint immunologiques Annales de Dermatologie et de Vénéréologie ·V. Sibaud, S. Boulinguez, C. Pagès, Laurent Riffaud, Laurence Lamant, C. Chira, Sabrina Boyrie, Émmanuelle Vigarios, É. Tournier, Nicolás Meyer	2018	13
10	Diagnosis, biology and epidemiology of oligometastatic breast cancer The Breast ·Jean‐Louis Lacaze, R. Aziza, C. Chira, Eléonora De Maio, F. Izar, Eva Jouve, Carole Massabeau, Anne Pradines, Gabrielle Selmes, Mony Ung, Slimane Zerdoud, Florence Dalenc	2021	6
11	PD-1 inhibitors might limit the development of brain metastases in patients with advanced melanoma Melanoma Research ·M. Marcaillou, Clara Linder, Léonor Chaltiel, V. Sibaud, Cécile Pagès, A. Modesto, C. Chira, Céline Dalmasso, S. Boulinguez, C. Bédane, Nicolás Meyer	2020	6
12	Systemic treatment with or without ablative therapies in oligometastatic breast cancer: A single institution analysis of patient outcomes The Breast ·Gauthier Glemarec, Jean‐Louis Lacaze, Bastien Cabarrou, R. Aziza, Eva Jouve, Slimane Zerdoud, Eléonora De Maio, Carole Massabeau, Maxime Loo, Vincent Esteyrie, Mony Ung, Florence Dalenc, F. Izar, C. Chira	2022	5
13	Unusually high prostate-specific antigen bounce after prostate brachytherapy: Searching for etiologic factors Brachytherapy ·C. Chira, Daniel Taussky, Nelson Gruszczynski, Aliza Meissner, Sandra Larrivée, Jean‐François Carrier, David Donath, Guila Delouya	2013	5
14	Prise en charge des patients atteints de métastases cérébrales de mélanome Cancer/Radiothérapie ·A. Modesto, C. Chira, Jean Christophe Sol, V. Lubrano, S. Boulinguez, C. Pagès, V. Sibaud, Carlos Gomez‐Roca, E. Cohen-Jonathan Moyal, Nicolás Meyer	2019	5
15	Haute dose dans la prostate par radiothérapie guidée par l’image : apport de l’arcthérapie avec modulation d’intensité du faisceau Cancer/Radiothérapie ·F. Jouyaux, R. de Crevoisier, J.-P. Manens, J. Bellec, Guillaume Cazoulat, Pascal Haigron, C. Chira, É. Le Prisé, C. Lafond	2010	5
16	CT-Guided Transthoracic Core-Needle Biopsy of Pulmonary Nodules: Current Practices, Efficacy, and Safety Considerations Journal of Clinical Medicine ·Amalia Constantinescu, Emil Robert Stoicescu, Roxana Iacob, C. Chira, Daiana Marina Cocolea, Alin Nicola, Roxana Mladin, Cristian Oancea, Diana Manolescu	2024	4
17	Preliminary experience of whole-brain radiation therapy (WBRT) in breast cancer patients with brain metastases previously treated with bevacizumab-based chemotherapy Journal of Neuro-Oncology ·C. Chira, Julian Jacob, N. Derhem, Marc A. Bollet, François Campana, Virginie Marchand, Jean‐Yves Pierga, Alain Fourquet, Youlia Kirova	2011	4
18	Survival estimation of melanoma patients with brain metastasis using the Melanoma-molGPA score: external validation from a French cohort Melanoma Research ·Céline Dalmasso, Cécile Pagès, Léonor Chaltiel, A. Brun, V. Sibaud, S. Boulinguez, C. Chira, Elizabeth Cohen‐Jonathan Moyal, V. Lubrano, Nicolás Meyer, A. Modesto	2020	3
19	Radiothérapie guidée par l’image : pourquoi, comment et résultats Bulletin du Cancer ·R. de Crevoisier, G. Louvel, Guillaume Cazoulat, Julie Leseur, C. Lafond, K. Lahbabi, C. Chira, J-L Lagrange	2009	3
20	Benefit of IMRT in High Dose Prostate Cancer Radiotherapy International Journal of Radiation OncologyBiologyPhysics ·R. de Crevoisier, C. Chira, C. Lafond, Laurence Crouzet, Antoine Simon, G. Louvel, Julie Leseur, J.-P. Manens, É. Le Prisé	2010	3

About C. Chira

C. Chira is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Radiation, Cancer Research and Surgery, having authored 34 papers that have together received 333 indexed citations. Recurring topics across this work include Advanced Radiotherapy Techniques (11 papers), Brain Metastases and Treatment (10 papers), Prostate Cancer Diagnosis and Treatment (9 papers), Breast Cancer Treatment Studies (7 papers), Prostate Cancer Treatment and Research (6 papers), Glioma Diagnosis and Treatment (5 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Melanoma and MAPK Pathways (3 papers). The work is most often cited by research in Radiation (117 citations), Pulmonary and Respiratory Medicine (194 citations), Oncology (130 citations), Radiology, Nuclear Medicine and Imaging (86 citations) and Cancer Research (37 citations). C. Chira has collaborated with scholars based in France, Colombia and United States. Frequent co-authors include V. Beckendorf, R. de Crevoisier, S. Boulinguez, V. Sibaud, Nicolás Meyer, A. Modesto, Léonor Chaltiel, Oscar Acosta, Alberto Bossi and Juan David Ospina. Their work appears in journals such as Melanoma Research, International Journal of Radiation Oncology*Biology*Physics, The Breast, Cancers and Radiation Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact